glp 1 blockers GLP-1-directed NMDA receptor antagonism for obesity treatment GLP-1 Agonists For Obesity In

The mechanisms by which peptides exert their therapeutic effects are diverse, ranging from hormone replacement and receptor modulation to enzyme inhibition, direct cellular interactions, and tissue repair processes

doi: 10.1089/hum.2024.084 129 LiWSunJFengSLWangFMiaoMZWuEY

A total concentration of 2 mM was injected intraperitoneally (IP) in a volume of 200 l/20 g body weight, equivalent to 5.2 mg/kg Fer1, 6.8 mg/kg Lip1, and 12.35 mg/kg UAMC-3203

The cycle structure exists for a practical reason: continuous stimulation of the same receptor pathways can lead to reduced sensitivity over time, and a rest period allows the system to reset before the next cycle produces full effect

Nature 367 , 645648 (1994)